| |
Diagnosis
|
|---|
| |
RA/ inflammatory arthritis
|
OA
|
AVN
|
Other
|
|---|
|
Overall moderate-severe ADL limitation
| | | | |
|
Two-year follow-up
|
67/140 (47.9%)
|
1384/4714 (29.4%)
|
115/389 (29.6%)
|
83/192 (43.2%)
|
|
P-value compared to RA group
| |
<0.01
|
<0.01
|
0.43
|
|
Five-year follow-up
|
45/97 (46.4%)
|
911/2648 (34.4%)
|
77/246 (31.3%)
|
62/139 (44.6%)
|
|
P-value compared to RA group
| |
0.01
|
0.02
|
0.79
|
|
Moderate-severe hip pain
| | | | |
|
Two-year follow-up
|
7/142 (4.9%)
|
355/4676 (7.6%)
|
47/378 (12.4%)
|
26/194 (13.4%)
|
|
P-value compared to RA group
| |
0.02
|
0.24
|
0.01
|
|
Five-year follow-up
|
7/93 (7.5%)
|
270/2651 (10.2%)
|
37/244 (15.2%)
|
25/142 (17.6%)
|
|
P-value compared to RA group
| |
0.07
|
0.41
|
0.03
|
- Reference category is rheumatoid arthritis/inflammatory arthritis and P-values were obtained from univariate logistic regression models. Numbers in bold represents significant p-value <0.05. ADL, activities of daily living; AVN, avascular necrosis of bone; OA, osteoarthritis; RA, rheumatoid arthritis; THA, total hip arthroplasty.
